Selenium and Mobility decreased - a phase IV clinical study of FDA data

Summary:

Mobility decreased is reported as a side effect among people who take Selenium (selenium), especially for people who are female, 60+ old, also take Vitamin C, and have Breast cancer.

The phase IV clinical study analyzes which people have Mobility decreased when taking Selenium. It is created by eHealthMe based on reports of 5,049 people who have side effects when taking Selenium from the FDA, and is updated regularly.

What is Selenium?

Selenium has active ingredients of selenium. It is often used in vitamin supplementation. eHealthMe is studying from 5,314 Selenium users. Check the latest studies of Selenium.

What is Mobility decreased?

Mobility decreased (ability to move is reduced) is found to be associated with 1,776 drugs and 1,636 conditions by eHealthMe. Check the latest studies of Mobility decreased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

5,049 people reported to have side effects when taking Selenium.
Among them, 32 people (0.63%) have Mobility decreased.

Could Selenium cause Mobility decreased?

Among these 32 people:

What is the gender of people who have Mobility decreased when taking Selenium? *

female: 65.38 %
male: 34.62 %

What is the age of people who have Mobility decreased when taking Selenium? *

What are other drugs people take besides Selenium? *

What are other side effects people have besides Mobility decreased? *

Joint Pain: 15 people, 46.88%
Muscle Aches (muscle pain): 10 people, 31.25%
Weakness: 8 people, 25.00%
Discomfort: 7 people, 21.88%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 5 people, 15.62%
Fatigue (feeling of tiredness): 5 people, 15.62%
Fall: 5 people, 15.62%
Muscle Spasms (muscle contraction): 4 people, 12.50%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 12.50%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 12.50%

What are the existing conditions these people have? *

Breast Cancer: 8 people, 25.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 21.88%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 18.75%
High Blood Cholesterol: 4 people, 12.50%
Sleep Disorder: 4 people, 12.50%
High Blood Pressure: 4 people, 12.50%
Gait Disturbance: 3 people, 9.38%
Pain: 3 people, 9.38%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 6.25%
Joint Pain: 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Selenium and have Mobility decreased?

- Check whether Mobility decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Selenium:

Selenium (5,314 reports)

Browse all side effects of Selenium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Mobility decreased:

Mobility decreased (1,776 drugs)

Browse all the conditions that are associated with Mobility decreased:

Mobility decreased (1,636 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on selenium (the active ingredients of Selenium) and Selenium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.